School of Applied Sciences

  • United Kingdom

Research Output

Filter
Patent
2018

Electrochromic compounds and optical articles containing them

Heron, M., Gabbutt, C. & Aiken, S., 12 Jul 2018, Patent No. WO2018127540, 4 Jan 2018, Priority date 9 Jan 2017

Research output: Patent

Use of Phytocannabinoids in the treatment of ovarian carcinoma.

Javid, F., 2018, IPC No. HGF Ltd, Patent No. US10098867, 19 Jun 2014, Priority date 16 Oct 2016

Research output: Patent

2017

COMPOSITION AND APPARATUS FOR TREATMENT OF CHEMOTHERAPY INDUCED ALOPECIA

Georgopoulos, N., 28 Dec 2017, IPC No. A61F7/10; A61K31/198; A61K31/352;, Patent No. WO2017220998A1, Priority No. GB201610910A·2016-06-22

Research output: Patent

Electrochromic compounds and optical articles containing them

Heron, M., Gabbutt, C. & Aiken, S., 12 Jan 2017, Patent No. WO2017005824, 6 Jul 2016, Priority date 8 Jul 2015

Research output: Patent

Patent: Methods for Producing Sporting Goods and Sporting Good

Nurnberg, HP., Hanson, HN., O'Haire, T., Loehner, MJ., Drummer, DK., Hohensinner, H., Lucht, MM., Vetter, J., Schmidt, W., Schmidt, A., Stark, N., Hohenberger, M., Prissok, F., Lintner, SKR., Tausif, M., Russell, S. J. & Goswami, P., 2017, University of Leeds, 28 Nov 2017, Priority date 31 May 2018, Priority No. US20180147752A1

Research output: Patent

The use of phytocannabinoids in the treatment of ovarian carcinoma

Javid, F., 2017, IPC No. HGF Ltd, Patent No. GB2014006473, 10 Apr 2014, Priority date 8 Feb 2017, Priority No. GB2516335B

Research output: Patent

2016

The use of phytocannabinoids in the treatment of ovarian carcinoma

Javid, F., 2016, IPC No. HGF Ltd, Patent No. EP2014732614, 19 Jun 2014, Priority date 27 Apr 2016, Priority No. EP3010498A1

Research output: Patent

2015

Electrochromic single and two-core viologens and optical articles containing them

Heron, M., Gabbutt, C. & Aiken, S., 26 Mar 2015, Patent No. WO2015040033 , 16 Sep 2014, Priority date 17 Sep 2013

Research output: Patent

Electrochromic two-core viologen derivatives and optical articles containing them

Heron, M., Gabbutt, C., Aiken, S. & Crossley, D., 26 Mar 2015, Patent No. WO2015040031, 16 Sep 2014, Priority date 17 Sep 2013

Research output: Patent

The use of phytocannabinoids in the treatment of ovarian and skin carcinoma

Javid, F., 2015, IPC No. HGF Ltd, Patent No. GB2014006473, 10 Apr 2014, Priority date 21 Jan 2015, Priority No. GB2516335A

Research output: Patent

2014

Apparatus and method for testing medicaments

Merchant, H., Frost, J. & Basit, A., 25 Jun 2014, IPC No. GB2509286, Patent No. 2509286, Priority date 2 May 2012, Priority No. 1207677

Research output: Patent

Open Access
File

Composition and use thereof

Georgopoulos, N., 4 Feb 2014, IPC No. Bailey Walsh, South Korea, Patent No. 10-2015-7024224, 4 Feb 2014

Research output: Patent

Composition and use thereof

Georgopoulos, N., 4 Feb 2014, IPC No. Bailey Walsh, Australia, Patent No. 2014210908, 4 Feb 2014

Research output: Patent

Composition and use thereof

Georgopoulos, N., 4 Feb 2014, IPC No. Bailey Walsh, Canada, Patent No. 2904260, 4 Feb 2014

Research output: Patent

Composition and use thereof

Georgopoulos, N., 4 Feb 2014, IPC No. Bailey Walsh, Europe, Patent No. 14705856.4, Priority No. 2950788

Research output: Patent

The use of phytocannabinoids in the treatment of ovarian carcinoma

Javid, F., 2014, Patent No. PCT/GB2014/051889, 19 Jun 2014, Priority date 24 Dec 2014, Priority No. WO2014202990A1

Research output: Patent

The use of phytocannabinoids in the treatment of ovarian carcinoma

Javid, F., 2014, IPC No. HGF Ltd, Patent No. GB2013010910, 19 Jun 2013, Priority date 24 Dec 2014, Priority No. GB2515312A

Research output: Patent

2011

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2011, IPC No. HGF, Patent No. EP2010180472, 3 Feb 2003, Priority date 16 Feb 2011, Priority No. EP2283832A1

Research output: Patent

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2011, IPC No. HGF, Patent No. US10/502822, 3 Feb 2003, Priority date 11 Oct 2011, Priority No. US8034843

Research output: Patent

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2011, IPC No. HGF, Patent No. EP2010180470, 3 Feb 2003, Priority date 19 Jan 2011, Priority No. EP2275097A1

Research output: Patent

2010

Method for the generation of a skin model and skin model

Eckl, K. & Hennies, H., 2010, 1 Apr 2009, Priority date 27 Oct 2010, Priority No. EP2243825A1

Research output: Patent

2005

Compositions for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2005, IPC No. HGF, Patent No. GB2002006183, 15 Mar 2002, Priority date 16 Nov 2005, Priority No. GB2384707B

Research output: Patent

2004

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2004, IPC No. HGF, Patent No. EP2003734779, 3 Feb 2003, Priority date 8 Dec 2004, Priority No. EP1482917A1

Research output: Patent

2003

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2003, IPC No. HGF, Patent No. AU2003239447, 3 Feb 2003, Priority date 2 Sep 2003, Priority No. AU2003239447A1

Research output: Patent

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Javid, F., 2003, IPC No. HGF, Patent No. PCT/GB2003/000451, 3 Feb 2003, Priority date 7 Aug 2003, Priority No. WO2003063847A1

Research output: Patent